Ablative Solutions today announced it completed the fourth tranche of its Series D financing round and raised $91.4 million. Wakefield, Massachusetts-based Ablative Solutions earmarked the funds to complete the company's ongoing Target BPI pivotal trial that is evaluating its alcohol-mediated renal denervation procedure. "We are extremely … [Read more...] about Ablative Solutions raises $91.4M in Series D financing round

Ablative Solutions announced today that it received positive results at six months from its post-market study for the Peregrine System infusion catheter, which accomplishes renal denervation by delivering microdoses of dehydrated alcohol. The results from the study of the safety and efficacy of the CE-Marked Peregrine System have been published … [Read more...] about Ablative Solutions touts study of its infusion catheter for renal denervation